CCM
CFRX

Chiron Capital Management’s ContraFect Corporation CFRX Stock Holding History

Chiron Capital Management’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6
Closed -$3K – 514
2020
Q3 		$3K Buy
+6
New +$2.72K ﹤0.01% 433

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chiron Capital Management's CFRX Position: Q4 2020 in Review

Chiron Capital Management sold out of ContraFect Corporation (CFRX) in Q4 2020, closing a stake of 6 shares — an estimated $3K sold.

Chiron Capital Management first reported a position in CFRX in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 61 funds tracked by Wall St. Rank hold CFRX as of Q4 2020.

  • Chiron Capital Management reported no remaining ContraFect Corporation position as of Q4 2020 after selling out during the quarter.
  • Chiron Capital Management sold 6 ContraFect Corporation shares in Q4 2020, an estimated $3K.
  • Chiron Capital Management first reported a position in ContraFect Corporation in Q3 2020 and held it in 1 quarter.
  • Chiron Capital Management's ContraFect Corporation position peaked at $3K in Q3 2020.
  • 61 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.